🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to determine how effective and safe the study...
Status
Completed
Location
Arizona Arthritis & Rheumatology Associates, P.C.
Start Date
2017-01-25
Trial ID
NCT02760433
Treatments Being Tested
The treatment of the new coronavirus infection (COVID-19) and COVID-19-asso...
Status
Completed
Location
I.M. Sechenov First Moscow State Medical University
Start Date
2020-12-10
Trial ID
NCT04854941
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of a single ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-06-30
Trial ID
NCT04452474
Treatments Being Tested
The purpose of this study is to evaluate the long term safety and tolerabil...
Status
Terminated
Location
166
Start Date
2011-03-07
Trial ID
NCT01296711
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of olokizuma...
Status
Active Not Recruiting
Location
Udmurt Republic Clinical and Diagnostic Center, Ministry of Health of the Udmurt Republic
Start Date
2025-06-11
Trial ID
NCT07670546
Treatments Being Tested
The primary purpose of this multi-centre, double blind-study is to evaluate...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01635621
Treatments Being Tested
Olokizumab (OKZ) has been shown to reverse the inhibitory effect of IL-6 on...
Status
Completed
Location
Comac Medical Ltd
Start Date
2021-11-16
Trial ID
NCT04246762
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy and safety ...
Status
Completed
Location
102
Start Date
2011-10
Trial ID
NCT01463059
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of olokizumab ...
Status
Recruiting
Location
Regional Clinical Hospital Regional state budgetary healthcare institution
Start Date
2023-08-23
Trial ID
NCT06440746
The study purpose was to assess the outcomes of therapy with olokizumab wit...
Status
Completed
Location
Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" under the Ministry of Health of the Russian Federation
Start Date
2021-07-14
Trial ID
NCT05196477
Treatments Being Tested